Nord/LB Analysts Give Bayer (FRA:BAYN) a €64.00 Price Target

Nord/LB set a €64.00 ($74.42) target price on Bayer (FRA:BAYN) in a research note released on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the healthcare company’s stock.

Several other equities analysts also recently issued reports on the stock. Barclays set a €85.00 ($98.84) price target on shares of Bayer and gave the company a buy rating in a research note on Friday, August 16th. HSBC set a €63.00 ($73.26) price target on shares of Bayer and gave the company a neutral rating in a research note on Wednesday, August 7th. Goldman Sachs Group set a €77.00 ($89.53) price target on shares of Bayer and gave the company a buy rating in a research note on Wednesday. Berenberg Bank set a €67.00 ($77.91) price target on shares of Bayer and gave the company a neutral rating in a research note on Wednesday, July 31st. Finally, UBS Group set a €110.00 ($127.91) price target on shares of Bayer and gave the company a buy rating in a research note on Monday, August 5th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have given a buy rating to the company. The stock has an average rating of Hold and a consensus target price of €81.43 ($94.69).

BAYN stock opened at €66.59 ($77.43) on Wednesday. The company has a fifty day moving average price of €60.79 and a 200-day moving average price of €61.00. Bayer has a 52-week low of €91.58 ($106.49) and a 52-week high of €123.82 ($143.98).

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: The role of implied volatility with call option volume

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.